Galenos Research

Dallas, Texas 75251

0 studies enrolling now · 16 studies all time

What they study most

Back Pain Lower Back Chronic, Chronic Pain, Diabetes Mellitus, Type 2, Diabetes Type 2, Heterozygous Familial Hypercholesterolemia, Hypertension, Opioid-induced Bowel Dysfunction, Osteoarthritis, Osteoarthritis, Hip, Osteoarthritis, Knee, Type 1 Diabetes, Type 2 Diabetes

Studies at this site

• A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes — Completed
• Investigational Study of Delayed Release Metformin — Paused
• A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus — Completed
• Opioid-induced Bowel Dysfunction (OBD) Pivotal Assessment of Lubiprostone (OPAL) — Completed
• Long Term Safety and Efficacy Study of Tanezumab in Subjects With Osteoarthritis of the Hip or Knee — Completed
• A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus — Stopped early
• Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM — Completed
• A 52 Week Study To Assess The Use Of Bococizumab (PF-04950615; RN316) In Subjects With Heterozygous Familial Hypercholesterolemia — Completed
• A 2-Month Safety Follow-Up Trial — Completed
• Naturlose (D-Tagatose) Efficacy Evaluation Trial — Completed
• Efficacy and Safety in Subjects With Type 2 Diabetes Receiving Subcutaneous Basal Insulin and Prandial Inhalation of Technosphere/Insulin Versus Subcutaneous Premixed Insulin Therapy Over a 52-Week Treatment Period and a 4-Week Follow-up — Completed
• DORADO-AC - Optimized Doses of Darusentan as Compared to an Active Control in Resistant Hypertension — Completed
• DORADO-AC-EX - A Long-Term Safety Extension Study to the Phase 3 DORADOC-AC Study (Protocol DAR-312) of Darusentan in Resistant Hypertension — Stopped early
• Safety of BTDS in Subjects With Low Back Pain: A 52-Week Extension Phase of BUP3015 — Stopped early
• Safety and Efficacy of Buprenorphine Transdermal System (BTDS) in Subjects With Moderate to Severe Low Back Pain — Stopped early
• Rates of Gastric Ulcer by Endoscopy in Knee Osteoarthritis Patients Receiving LT-NS001 Versus Naprosyn® — Completed